For the year ending 2025-12-31, BNGO made $28,508K in revenue. -$26,395K in net income. Net profit margin of -92.59%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Total revenue | 28,508 | 30,776 | ||
| Product | 14,429 | - | ||
| Product And Service Other | 894 | - | ||
| Total cost of revenue | 15,323 | 30,396 | ||
| Research and development | 11,374 | 24,803 | ||
| Selling, general and administrative | 35,150 | 51,855 | ||
| Intangible assets and other long-lived assets impairment | 0 | 19,683 | ||
| Restructuring costs | 0 | 8,022 | ||
| Total operating expenses | 46,524 | 104,363 | ||
| Loss from operations | -33,339 | -103,983 | ||
| Interest income | 1,111 | 2,101 | ||
| Other income (expense) | 5,900 | -10,102 | ||
| Total other income (expense) | 7,011 | -8,001 | ||
| Loss before income taxes | -26,328 | -111,984 | ||
| Provision for income taxes | 67 | 33 | ||
| Net loss | -26,395 | -112,017 | ||
| Basic EPS | -4.85 | -88.13 | ||
| Diluted EPS | -4.85 | -88.13 | ||
| Basic Average Shares | 5,445,000 | 1,271,000 | ||
| Diluted Average Shares | 5,445,000 | 1,271,000 | ||
Bionano Genomics, Inc. (BNGO)
Bionano Genomics, Inc. (BNGO)